Skip to main content

Advertisement

Log in

The Use of Alefacept in the Treatment of Psoriasis

  • Published:
Journal of Cutaneous Medicine & Surgery

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

FIGURE 1
FIGURE 2

References

  1. GG Krueger KP. Callis (2003) ArticleTitleDevelopment and use of alefacept to treat psoriasis J Am Acad Dermatol 49 S87–S97 Occurrence Handle10.1016/mjd.2003.552 Occurrence Handle12894131

    Article  PubMed  Google Scholar 

  2. U. Mrowietz (2001) ArticleTitleAdvances in systemic therapy for psoriasis Clin Exp Dermatol 26 362–367 Occurrence Handle10.1046/j.1365-2230.2001.00835.x Occurrence Handle1:STN:280:DC%2BD3MzmtFyltw%3D%3D Occurrence Handle11422190

    Article  CAS  PubMed  Google Scholar 

  3. JP Callen GG Kruger M Lebwohl et al. (2003) ArticleTitleAAD consensus statement on psoriasis therapies J Am Acad Dermatol 49 897–899 Occurrence Handle10.1016/S0190-9622(03)01870-X Occurrence Handle14576671

    Article  PubMed  Google Scholar 

  4. GG. Krueger (2002) ArticleTitleSelective targeting of T-cells subsets: Focus on alefacept-a remitting therapy for psoriasis Expert Opin Biol Ther 2 431–441 Occurrence Handle1:CAS:528:DC%2BD38Xkt1Ckur4%3D Occurrence Handle11955280

    CAS  PubMed  Google Scholar 

  5. JC. Prinz (2003) ArticleTitleThe role of T-cells in psoriasis J Eur Acad Dermatol Venereol 17 257–270 Occurrence Handle1:STN:280:DC%2BD3s3jslKqtA%3D%3D Occurrence Handle12702062

    CAS  PubMed  Google Scholar 

  6. CN Ellis GG. Krueger (2001) ArticleTitleTreatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes N Engl J Med 345 248–255 Occurrence Handle10.1056/NEJM200107263450403 Occurrence Handle1:CAS:528:DC%2BD3MXlvVKqs7Y%3D Occurrence Handle11474662

    Article  CAS  PubMed  Google Scholar 

  7. M Lebwohl E Christophers R Langley et al. (2003) ArticleTitleAn international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis Arch Dermatol 139 719–727

    Google Scholar 

  8. KB Gordon R. Langley (2003) ArticleTitleRemittive effects of intramuscular alefacept in psoriasis J Drugs Dermatol 2 494–500

    Google Scholar 

  9. RG Langley D Baker J. Roberts (2004) ArticleTitleThe safety of alefacept using a reduced schedule for monitoring T-cells J Am Acad Dermatol 50 152 Occurrence Handle10.1016/j.jaad.2003.10.533

    Article  Google Scholar 

  10. M. Lebwohl (2003) ArticleTitleCombining the new biologic agents with our current psoriasis armamentarium J Am Acad Dermatol 49 S118–S124 Occurrence Handle10.1016/S0190-9622(03)01144-7 Occurrence Handle12894135

    Article  PubMed  Google Scholar 

  11. Koo J. Combination therapy with alefacept plus broadband ultraviolet B light for treatment of psoriasis. Presented at International Psoriasis Symposium, June 18–22, 2003, New York

  12. Ortonne JP, Khemis A. Combination therapy with alefacept plus narrowband ultraviolet B light for treatment of psoriasis. Presented at International Psoriasis Symposium, June 18–22, 2003, New York

Download references

Author information

Authors and Affiliations

Authors

About this article

Cite this article

Langley, R., Gupta, A.K., Poulin, Y. et al. The Use of Alefacept in the Treatment of Psoriasis . J Cutan Med Surg 8 (Suppl 1), 14–18 (2004). https://doi.org/10.1007/s10227-004-2004-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10227-004-2004-5

Keywords

Navigation